Hippocratic AI Establishes a Healthcare Advisory Board Comprised of Seven Industry Visionaries and Business Leaders

Hippocratic AI Establishes a Healthcare Advisory Board Comprised of Seven Industry Visionaries and Business Leaders

Media:
Rick Keating
rkeating@keatingco.com
917 767 2400

Hippocratic AI, the company building the first safety-focused Large Language Model (LLM) for healthcare, today announced the establishment of its Healthcare Advisory Board and its members.

The board's purpose is to help guide the company on broad issues in the healthcare industry, including economics, governmental policy, risk management, research, and macro-level trends. This board complements Hippocratic AI’s Physician and Nurse Advisory Councils, which provide primarily clinical and workforce-specific input to the company.

The inaugural members of the Hippocratic AI Healthcare Advisory Board are:

Scott Becker – Founder, Publisher, and Chief Content Officer of Beckers Healthcare, a leading healthcare media company, Founder and Publisher Becker Private Equity and Business, and a Partner at McGuireWoods LLP, a healthcare transactional and regulatory law firm.

Toby Cosgrove M.D. – Executive Advisor and former CEO and President of Cleveland Clinic, the over $5 billion healthcare system comprised of the Cleveland Clinic, nine community hospitals, 15 family health and ambulatory surgery centers, Cleveland Clinic Florida, the Lou Ruvo Center for Brain Health in Las Vegas, Nevada, Cleveland Clinic Toronto, and Cleveland Clinic Abu Dhabi.

Stephen Klasko M.D. – Executive in Residence at the General Catalyst venture capital firm and Board Chair of DocGo, a provider of high-quality medical care outside of traditional hospital or clinic settings. He is the former President and CEO of Thomas Jefferson University and Jefferson Health, which includes 18 hospitals and 35,000 employees in the Philadelphia region.

Dr. Richard Klausner – Founder and Co-Chair of Altos Labs, Founder and Chairman of Lyell Immunopharma, Co-Founder and Chairman of LifeMine Therapeutics, Board Chair of Parabilis Medicines, Sonoma Biotherapeutics, and Board Member of Ohalo, all biotechnology companies. He is the former Executive Director of Global Health for the Bill and Melinda Gates Foundation and former Director of the US National Cancer Institute.

Larry Leisure – Co Founder & Co-Managing Partner of Chicago Pacific Founders, a Chicago & San Francisco based healthcare-focused private equity firm, Chairman, UCSF Rosenman Institute Advisory Board, Board Member, UCLA Anderson Board of Advisors, and Senior Advisor, Stanford Mussallem Center for BIODESIGN. Previously served as Operating Partner, Kleiner Perkins, and Managing Partner, Accenture.

Lee Shapiro – Co-Founder/Partner, 7wire Ventures, a creator and investor in early and growth stage healthcare businesses. He is also a current board member of several healthcare-related companies, including Clover Health [NASDAQ:CLOV], Parsley Health, Override Health, Folx Health, PayZen, Jasper Health, and Click Therapeutics.

J. Eric Smith – Former President and CEO of Swiss Re Americas. The Swiss Re Group is one of the world's leading providers of reinsurance, insurance, and other forms of insurance-based risk transfer. He is also an independent Board Director of ORI and Fairmatic, and a member of the Global Advisory Board of Jefferies, the investment banking and capital markets firm.

“Healthcare, writ large, including providers, payers, pharma, legislators, and regulators, is complex and ever evolving, and we need the deep knowledge and experience of leaders who have dealt with its broad range of issues to navigate its future course,” said Munjal Shah, co-founder and CEO of Hippocratic AI. “I’m proud that what Hippocratic AI has achieved so far has made it possible for such an esteemed group of advisors to form our Healthcare Advisory Board as we pursue our vision of delivering healthcare abundance with generative AI.”

About Hippocratic AI

Hippocratic AI’s mission is to develop the first safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Washington University in St. Louis, Stanford, Google, and NVIDIA. Hippocratic AI has received a total of $137 million in funding and is backed by leading investors, including General Catalyst, Andreessen Horowitz, Premji Invest, SV Angel, NVentures, and Greycroft. For more information on Hippocratic AI: www.HippocraticAI.com.